CCL20



CCL20

A1AA1S2SS2N3NN3F4FF4D5DD5C6CC6C7CC7L8LL8G9GG9Y10YY10T11TT11D12DD12R13RR13I14II14L15LL15H16HH16P17PP17K18KK18F19FF19I20II20V21VV21G22GG22F23FF23T24TT24R25RR25Q26QQ26L27LL27A28AA28N29NN29E30EE30G31GG31C32CC32D33DD33I34II34N35NN35A36AA36I37II37I38II38F39FF39H40HH40T41TT41K42KK42K43KK43K44KK44L45LL45S46SS46V47VV47... and 23 more residue(s)...... and 23 more residue(s)

SMILES None
InChIKey None
Sequence ASNFDCCLGYTDRILHPKFIVGFTRQLANEGCDINAIIFHTKKKLSVCANPKQTWVKYIVRLLSKKVKNM

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections

Structure pdb 6WWZ

Bioactivities

CCL20

A1AA1S2SS2N3NN3F4FF4D5DD5C6CC6C7CC7L8LL8G9GG9Y10YY10T11TT11D12DD12R13RR13I14II14L15LL15H16HH16P17PP17K18KK18F19FF19I20II20V21VV21G22GG22F23FF23T24TT24R25RR25Q26QQ26L27LL27A28AA28N29NN29E30EE30G31GG31C32CC32D33DD33I34II34N35NN35A36AA36I37II37I38II38F39FF39H40HH40T41TT41K42KK42K43KK43K44KK44L45LL45S46SS46V47VV47... and 23 more residue(s)...... and 23 more residue(s)

Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections

Structure pdb 6WWZ

Compound is not listed as a drug.